T

Trajan Group Holdings Ltd
ASX:TRJ

Watchlist Manager
Trajan Group Holdings Ltd
ASX:TRJ
Watchlist
Price: 1.095 AUD 7.35%
Market Cap: 166.7m AUD
Have any thoughts about
Trajan Group Holdings Ltd?
Write Note

Trajan Group Holdings Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Trajan Group Holdings Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
T
Trajan Group Holdings Ltd
ASX:TRJ
Cash from Financing Activities
-AU$6.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Anteotech Ltd
ASX:ADO
Cash from Financing Activities
AU$9.9m
CAGR 3-Years
-24%
CAGR 5-Years
24%
CAGR 10-Years
4%
Proteomics International Laboratories Ltd
ASX:PIQ
Cash from Financing Activities
AU$6.6m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Cash from Financing Activities
-AU$809.8k
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
-3%
Genetic Signatures Ltd
ASX:GSS
Cash from Financing Activities
AU$34.8m
CAGR 3-Years
N/A
CAGR 5-Years
168%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Cash from Financing Activities
-AU$582.5k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Trajan Group Holdings Ltd
Glance View

Market Cap
166.7m AUD
Industry
Life Sciences Tools & Services

Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.

TRJ Intrinsic Value
2.868 AUD
Undervaluation 62%
Intrinsic Value
Price
T

See Also

What is Trajan Group Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
-6.4m AUD

Based on the financial report for Jun 30, 2024, Trajan Group Holdings Ltd's Cash from Financing Activities amounts to -6.4m AUD.

What is Trajan Group Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-90%

Over the last year, the Cash from Financing Activities growth was -90%.

Back to Top